Counterpoint: Cervical cancer screening guidelines-approaching the golden age

American Journal of Epidemiology

Volumn 178, Issue 7, 2013, Pages 1023-1026

  Isidean, Sandra D ^a   Franco, Eduardo L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

cervical cancer; human papillomavirus; Papanicolaou smear; screening; women's health

Indexed keywords

AGE CLASS; CANCER; DECISION MAKING; ELDERLY POPULATION; EPIDEMIOLOGY; GUIDELINE; HEALTH POLICY; HEALTH SERVICES; PERCEPTION; REPRODUCTIVE HEALTH; WOMENS HEALTH;

ARTICLE; CANCER SCREENING; CARCINOGENESIS; COLPOSCOPY; FALSE POSITIVE RESULT; HUMAN; HYSTERECTOMY; LAW SUIT; LIFE EXPECTANCY; PAPANICOLAOU TEST; POSTMENOPAUSE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PROSTATE CANCER; SELF ESTEEM; SEXUALLY TRANSMITTED DISEASE; SWEDEN; UNITED KINGDOM; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

CERVICAL CANCER; HUMAN PAPILLOMAVIRUS; PAPANICOLAOU SMEAR; SCREENING; WOMEN'S HEALTH;

EARLY DETECTION OF CANCER; FEMALE; HUMANS; PRACTICE GUIDELINES AS TOPIC; UTERINE CERVICAL NEOPLASMS;

UNITED STATES;

HUMAN PAPILLOMAVIRUS;

EID: 84884949022     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt171     Document Type: Article

References (36)

1. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012; 62(3):147-172.
2. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52(6):342-362.
3. Moyer VA, US Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 156(12):880-891, W312.
4. Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin Number 131: screening for cervical cancer. Obstet Gynecol. 2012;120(5):1222-1238.
5. Schunemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336(7653):1106-1110.
6. Rustagi AS, Kamineni A,Weiss NS. Point: cervical screening guidelines should consider observational data on screening efficacy in older women. Am J Epidemiol. 2013;178(7): 1020-1022.
7. Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ. 2009;339:b2968.
8. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer. 2003;89(1):88-93.
9. Andrae B, Kemetli L, Sparen P, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008;100(9):622-629.
10. Kamineni A,Weinmann S, Shy KK, et al. Cervical cancer screening efficacy in older women. Cancer Epidemiol Biomarkers Prev. 2011;20(4):718-719.
11. Kulasingam SL, Havrilesky L, Ghebre R, et al. Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
12. Sawaya GF, Grady D, Kerlikowske K, et al. The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS). Ann Intern Med. 2000; 133(12):942-950.
13. Sawaya GF. Should routine screening Papanicolaou smears be done for women older than 65 years? Arch Intern Med. 2004;164(3):243-245.
14. Castle PE, Schiffman M, Wheeler CM, et al. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol. 2009;113(1):18-25.
15. Copeland G, Datta SD, Spivak G, et al. Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985-2003. Cancer. 2008;113(suppl 10): 2946-2954.
16. Bellizzi KM, Breslau ES, Burness A, et al. Prevalence of cancer screening in older, racially diverse adults: still screening after all these years. Arch Intern Med. 2011; 171(22):2031-2037.
17. Yabroff KR, Zapka J, Klabunde CN, et al. Systems strategies to support cancer screening in U.S. primary care practice. Cancer Epidemiol Biomarkers Prev. 2011; 20(12):2471-2479.
18. Gustafsson L, Sparen P, Gustafsson M, et al. Low efficiency of cytologic screening for cancer in situ of the cervix in older women. Int J Cancer. 1995;63(6):804-809.
19. VanWijngaarden WJ, Duncan ID. Rationale for stopping cervical screening in women over 50. BMJ. 1993;306(6883): 967-971.
20. Sigurdsson K. Trends in cervical intra-epithelial neoplasia in Iceland through 1995: evaluation of targeted age groups and screening intervals. Acta Obstet Gynecol Scand. 1999; 78(6):486-492.
21. Lawson HW, Lee NC, Thames SF, et al. Cervical cancer screening among low-income women: results of a national screening program, 1991-1995. Obstet Gynecol. 1998; 92(5):745-752.
22. Mandelblatt J, Gopaul I, Wistreich M. Gynecological care of elderly women: another look at Papanicolaou smear testing. JAMA. 1986;256(3):367-371.
23. Sawaya GF, Kerlikowske K, Lee NC, et al. Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol. 2000;96(2):219-223.
24. LeydenWA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005; 97(9):675-683.
25. Andrae B, Andersson TM, Lambert PC, et al. Screening and cervical cancer cure: population based cohort study. BMJ. 2012;344:e900.
26. Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med. 2007;45(2-3):93-106.
27. Gustafsson L, Ponten J, Zack M, et al. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control. 1997;8(5): 755-763.
28. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007; 370(9590):890-907.
29. Chen HC, Schiffman M, Lin CY, et al. Persistence of type-specific human papillomavirus infection and increased long-Term risk of cervical cancer. J Natl Cancer Inst. 2011; 103(18):1387-1396.
30. Rodriguez AC, Schiffman M, Herrero R, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst. 2010;102(5):315-324.
31. Brody H. From an ethics of rationing to an ethics of waste avoidance. N Engl J Med. 2012;366(21):1949-1951.
32. Bernstein R, DeJoseph D, Buchanan EM. When to stop screening: a review of breast, gynecologic, and colorectal cancer screening in women over age 65. Care Manag J. 2010;11(1):48-57.
33. Gates TJ. Screening for cancer: evaluating the evidence. Am Fam Physician. 2001;63(3):513-522.
34. Moyer VA, US Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 157(2):120-134.
35. Centers for Disease Control and Prevention. The State of Aging and Health in America. Whitehouse Station, NJ: Centers for Disease Control and Prevention and The Merck Company Foundation; 2007.
36. Fisher ES, Bynum JP, Skinner JS. Slowing the growth of health care costs-lessons from regional variation. N Engl J Med. 2009;360(9):849-852.